March 2024 - PharmaTimes

Published on 23 February 2024

Description:

PharmaTimes ventures into modern, progressive and inclusive terrain! Our cover story looks at how diversity in clinical trials is evolving and what has to be done to ignite it. Meanwhile, we look at the future of pharma through a very modern lens, at a time when our industry is entering a sustained chapter of change. With this considered, there are also features on the compelling influence of women in pharma, the spectre of AI, the health climate crisis and why Star Trek could influence emerging MedTech. Yes, this magazine is boldly visiting new, unchartered dimensions!

Categories:

PharmaTimes

Preview:

25 articles from this collection:

Cover

2 - Communique 2024

3 - From the editor

This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again there is much cause for celebration.

4-5 - Contents

6 - NEWS: Treatments

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the potential reclassification of two progestogen-only, oral contraceptive pills containing desogestrel: Lovima 75mcg and Hana 75mcg film-coated tablets.

7 - NEWS: Research

8 - NEWS: COLLABORATION

9 - NEWS: Conditions

10-12 - DIVERSITY - Eclectic mix

FLYPHARMA Europe

14-15 - WOMEN IN PHARMA: Passion project

16-17 - CLIMATE - Change is coming

18-19 - NIHR: Awaken the giant within

20-22 - INDUSTRY: Back to pharma’s future

23 - WOMEN IN PHARMA: Blueprint for inclusion

24-25 - MEDTECH: Live long and prosper?

26-27 - PHARMA: Exoso-what?

28-29 - THERAPIES: The eliminator

30-31 - MARKETING - Trend setters

32-33 - AI: Staying AI-head of the game!

34-35 - DATA - Big reset

36-37 - Your moves

38 - AI – Believe in the force

39 - PharmaRole

40 - Pharmatimes CROY

PharmaTimes

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

editorial@pharmatimes.com

https://pharmatimes.com/